 Michael Tchou
Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospitals, Pediatric | 16 | 2025 | 506 | 2.400 |
Why?
| | Electrolytes | 2 | 2019 | 58 | 1.180 |
Why?
| | Unnecessary Procedures | 2 | 2019 | 50 | 1.160 |
Why?
| | Curriculum | 5 | 2018 | 976 | 0.840 |
Why?
| | Diagnostic Tests, Routine | 1 | 2024 | 110 | 0.800 |
Why?
| | Community-Acquired Infections | 2 | 2022 | 169 | 0.800 |
Why?
| | Laboratories, Hospital | 2 | 2019 | 15 | 0.770 |
Why?
| | Pneumonia | 3 | 2024 | 635 | 0.750 |
Why?
| | Quality Improvement | 7 | 2025 | 1163 | 0.750 |
Why?
| | Respiratory Tract Infections | 2 | 2025 | 389 | 0.740 |
Why?
| | Clinical Laboratory Techniques | 2 | 2019 | 97 | 0.720 |
Why?
| | Pneumonia, Bacterial | 1 | 2022 | 116 | 0.710 |
Why?
| | Explosive Agents | 1 | 2020 | 6 | 0.680 |
Why?
| | Pediatrics | 6 | 2022 | 1096 | 0.670 |
Why?
| | Hospital Medicine | 1 | 2021 | 89 | 0.650 |
Why?
| | Medicine | 1 | 2021 | 121 | 0.640 |
Why?
| | Incidental Findings | 1 | 2020 | 87 | 0.640 |
Why?
| | Quality of Health Care | 4 | 2018 | 634 | 0.640 |
Why?
| | Urinary Tract Infections | 3 | 2025 | 188 | 0.560 |
Why?
| | Hospitalists | 1 | 2021 | 245 | 0.540 |
Why?
| | Child | 26 | 2025 | 21822 | 0.540 |
Why?
| | Education, Medical, Graduate | 2 | 2022 | 481 | 0.540 |
Why?
| | Child, Hospitalized | 3 | 2021 | 49 | 0.510 |
Why?
| | Internship and Residency | 3 | 2022 | 1132 | 0.510 |
Why?
| | Hospitalization | 10 | 2025 | 2183 | 0.490 |
Why?
| | Length of Stay | 8 | 2025 | 1205 | 0.480 |
Why?
| | Education, Medical | 2 | 2018 | 260 | 0.480 |
Why?
| | Patient Readmission | 5 | 2024 | 694 | 0.450 |
Why?
| | Anti-Bacterial Agents | 6 | 2025 | 1798 | 0.430 |
Why?
| | Urogenital Abnormalities | 2 | 2025 | 64 | 0.430 |
Why?
| | Pandemics | 1 | 2021 | 1613 | 0.400 |
Why?
| | Infant | 12 | 2025 | 9398 | 0.380 |
Why?
| | Cross-Sectional Studies | 10 | 2025 | 5423 | 0.370 |
Why?
| | Infant, Newborn | 8 | 2025 | 6033 | 0.360 |
Why?
| | Consumer Behavior | 2 | 2021 | 71 | 0.330 |
Why?
| | Attitude of Health Personnel | 1 | 2017 | 1163 | 0.320 |
Why?
| | Bacteremia | 2 | 2024 | 213 | 0.300 |
Why?
| | Retrospective Studies | 14 | 2025 | 15504 | 0.300 |
Why?
| | Humans | 37 | 2025 | 136764 | 0.300 |
Why?
| | Staff Development | 2 | 2018 | 56 | 0.280 |
Why?
| | Child, Preschool | 10 | 2025 | 11000 | 0.280 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 5742 | 0.240 |
Why?
| | Faculty, Medical | 2 | 2018 | 283 | 0.240 |
Why?
| | Appointments and Schedules | 1 | 2025 | 89 | 0.220 |
Why?
| | Accreditation | 2 | 2022 | 82 | 0.220 |
Why?
| | Vesico-Ureteral Reflux | 1 | 2024 | 32 | 0.220 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2024 | 10 | 0.220 |
Why?
| | Phlebotomy | 1 | 2024 | 21 | 0.220 |
Why?
| | Medical Errors | 1 | 2025 | 112 | 0.210 |
Why?
| | Scurvy | 1 | 2024 | 17 | 0.210 |
Why?
| | Urinary Tract | 1 | 2024 | 51 | 0.210 |
Why?
| | Catheterization, Central Venous | 1 | 2025 | 111 | 0.210 |
Why?
| | Adolescent | 10 | 2025 | 21382 | 0.200 |
Why?
| | Practice Patterns, Physicians' | 2 | 2025 | 1301 | 0.200 |
Why?
| | Seizures, Febrile | 1 | 2022 | 21 | 0.190 |
Why?
| | Patient Care Bundles | 1 | 2022 | 23 | 0.190 |
Why?
| | Parents | 2 | 2021 | 1340 | 0.180 |
Why?
| | Cost of Illness | 2 | 2021 | 302 | 0.180 |
Why?
| | Communicable Diseases | 1 | 2023 | 159 | 0.170 |
Why?
| | Hospital Costs | 1 | 2021 | 116 | 0.170 |
Why?
| | Fluid Therapy | 1 | 2022 | 147 | 0.170 |
Why?
| | Hospitals | 2 | 2024 | 685 | 0.170 |
Why?
| | Meningitis | 1 | 2021 | 79 | 0.160 |
Why?
| | Infusions, Parenteral | 1 | 2019 | 40 | 0.160 |
Why?
| | Encephalitis | 1 | 2021 | 136 | 0.160 |
Why?
| | Laboratories | 1 | 2020 | 112 | 0.160 |
Why?
| | Diarrhea | 1 | 2020 | 184 | 0.150 |
Why?
| | Soft Tissue Infections | 1 | 2019 | 37 | 0.150 |
Why?
| | Focus Groups | 1 | 2022 | 515 | 0.150 |
Why?
| | Administration, Intravenous | 1 | 2019 | 155 | 0.150 |
Why?
| | Gram-Positive Bacteria | 1 | 2018 | 48 | 0.150 |
Why?
| | Gastroenteritis | 1 | 2019 | 68 | 0.150 |
Why?
| | Bacteriological Techniques | 1 | 2018 | 73 | 0.140 |
Why?
| | Ohio | 1 | 2018 | 152 | 0.140 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2018 | 105 | 0.140 |
Why?
| | Drug Resistance, Bacterial | 1 | 2018 | 185 | 0.140 |
Why?
| | Anti-Infective Agents | 1 | 2019 | 254 | 0.130 |
Why?
| | Drug Costs | 1 | 2017 | 106 | 0.130 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 363 | 0.130 |
Why?
| | Health Care Costs | 1 | 2019 | 384 | 0.120 |
Why?
| | United States | 6 | 2025 | 14691 | 0.120 |
Why?
| | Male | 10 | 2025 | 67309 | 0.120 |
Why?
| | Delivery of Health Care | 2 | 2018 | 934 | 0.110 |
Why?
| | Amiodarone | 1 | 2014 | 26 | 0.110 |
Why?
| | Female | 10 | 2025 | 72787 | 0.110 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2014 | 114 | 0.110 |
Why?
| | Acute Kidney Injury | 1 | 2021 | 809 | 0.100 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2014 | 130 | 0.100 |
Why?
| | Learning | 1 | 2017 | 406 | 0.100 |
Why?
| | Biomedical Research | 1 | 2018 | 688 | 0.090 |
Why?
| | Clinical Competence | 1 | 2018 | 1094 | 0.090 |
Why?
| | Microbial Sensitivity Tests | 2 | 2024 | 357 | 0.080 |
Why?
| | Decision Making | 1 | 2017 | 898 | 0.080 |
Why?
| | Neoplasms | 1 | 2025 | 2644 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2667 | 0.080 |
Why?
| | Atrial Fibrillation | 1 | 2014 | 388 | 0.080 |
Why?
| | Emergency Service, Hospital | 3 | 2025 | 2046 | 0.070 |
Why?
| | Health Expenditures | 2 | 2019 | 186 | 0.060 |
Why?
| | Near Miss, Healthcare | 1 | 2025 | 11 | 0.060 |
Why?
| | Asthma | 1 | 2017 | 2282 | 0.050 |
Why?
| | Treatment Failure | 1 | 2024 | 354 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2024 | 176 | 0.050 |
Why?
| | Academic Medical Centers | 1 | 2025 | 504 | 0.050 |
Why?
| | Reference Standards | 1 | 2022 | 186 | 0.040 |
Why?
| | Benchmarking | 1 | 2022 | 183 | 0.040 |
Why?
| | Social Determinants of Health | 1 | 2024 | 255 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2022 | 497 | 0.040 |
Why?
| | Income | 1 | 2020 | 202 | 0.040 |
Why?
| | Health Surveys | 1 | 2021 | 513 | 0.040 |
Why?
| | Cost Savings | 1 | 2018 | 84 | 0.040 |
Why?
| | Los Angeles | 1 | 2018 | 76 | 0.040 |
Why?
| | Education | 1 | 2018 | 107 | 0.040 |
Why?
| | Insurance Coverage | 1 | 2019 | 229 | 0.030 |
Why?
| | Coinfection | 1 | 2018 | 137 | 0.030 |
Why?
| | Poverty | 1 | 2020 | 520 | 0.030 |
Why?
| | Health Services Research | 1 | 2018 | 399 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2018 | 587 | 0.030 |
Why?
| | Inpatients | 1 | 2019 | 496 | 0.030 |
Why?
| | Acute Disease | 1 | 2017 | 1004 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1231 | 0.030 |
Why?
| | Kidney | 1 | 2021 | 1467 | 0.030 |
Why?
| | Anti-Asthmatic Agents | 1 | 2017 | 393 | 0.030 |
Why?
| | Young Adult | 2 | 2019 | 13129 | 0.020 |
Why?
| | Critical Care | 1 | 2017 | 583 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2024 | 3555 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1321 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3264 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2750 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 6806 | 0.020 |
Why?
| | Adult | 2 | 2019 | 37630 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 33228 | 0.010 |
Why?
| | Cohort Studies | 1 | 2014 | 5701 | 0.010 |
Why?
| | Aged | 1 | 2014 | 23794 | 0.010 |
Why?
|
|
Tchou's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|